Zydus and Dr. Reddy to Co-Market Pertuzumab Biosimilar in India
Zydus Lifesciences and Dr. Reddy’s Laboratories Ltd. have announced the execution of a licensing agreement to co-market Pertuzumab biosimilar in India.
Zydus Research Centre | 05/07/2024 | By Aishwarya | 1556
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy